The rise in atmospheric chlorine levels caused by the emission of chlorofluorocarbons and other halocarbons is thought to be the main cause of the appearance of the Antarctic ozone 'hole' in the late 1970s, and the more modest ozone depletion observed over parts of the Northern Hemisphere. Atmospheric bromine, also associated with halocarbon emissions, is believed to contribute to ozone depletion. Over the next decade, further increases in these compounds are inevitable. Model calculations show that by the end of the next century, atmospheric chlorine and bromine levels may return to those prevalent before the onset of the ozone hole, but only if more stringent regulations are applied to halocarbon production than those currently proposed. © 1990 Nature Publishing Group.

Recent studies indicate that insulin stimulation of glucose transporter (GLUT)4 translocation requires at least two distinct insulin receptor-mediated signals: one leading to the activation of phosphatidylinositol 3 (PI-3) kinase and the other to the activation of the small GTP binding protein TC10. We now demonstrate that TC10 is processed through the secretory membrane trafficking system and localizes to caveolin-enriched lipid raft microdomains. Although insulin activated the wild-type TC10 protein and a TC10/H-Ras chimera that were targeted to lipid raft microdomains, it was unable to activate a TC10/K-Ras chimera that was directed to the nonlipid raft domains. Similarly, only the lipid raft-localized TC10/ H-Ras chimera inhibited GLUT4 translocation, whereas the TC10/K-Ras chimera showed no significant inhibitory activity. Furthermore, disruption of lipid raft microdomains by expression of a dominant-interfering caveolin 3 mutant (Cav3/DGV) inhibited the insulin stimulation of GLUT4 translocation and TC10 lipid raft localization and activation without affecting PI-3 kinase signaling. These data demonstrate that the insulin stimulation of GLUT4 translocation in adipocytes requires the spatial separation and distinct compartmentalization of the PI-3 kinase and TC10 signaling pathways.